Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

April 2021 | 89 pages | ID: M0E60528133EN
GlobalData

Abstracts

Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diodes (OLED) materials and cosmetic active ingredients. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Mar 17,2021: Gilead and Merck partner to co-develop long-acting HIV treatments
Mar 16,2021: Merck brings new renewable energy to the grid through virtual power purchase agreement with Enel Green Power
Mar 04,2021: Merck KGaA, Darmstadt, Germany moves the Silicon Valley Innovation Hub to San Jose's Intermolecular site
Mar 04,2021: Merck reports record results in a turbulent year
Mar 03,2021: GPHL and Merck build strategic partnership on business innovation and development in GBA

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Merck KGaA - Key Facts
Merck KGaA - Key Employees
Merck KGaA - Key Employee Biographies
Merck KGaA - Major Products and Services
Merck KGaA - History
Merck KGaA - Company Statement
Merck KGaA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate

SECTION 2 – COMPANY ANALYSIS

Company Overview
Merck KGaA - Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Life Science
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Middle East and Africa (MEA)
Performance
Geographical Segment: North America
Performance
R&D Overview
Merck KGaA - Corporate Strategy
Merck KGaA - SWOT Analysis
SWOT Analysis - Overview
Merck KGaA - Strengths
Merck KGaA - Weaknesses
Merck KGaA - Opportunities
Merck KGaA - Threats
Merck KGaA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merck KGaA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 17, 2021: Gilead and Merck partner to co-develop long-acting HIV treatments
Mar 16, 2021: Merck brings new renewable energy to the grid through virtual power purchase agreement with Enel Green Power
Mar 04, 2021: Merck KGaA, Darmstadt, Germany moves the Silicon Valley Innovation Hub to San Jose's Intermolecular site
Mar 04, 2021: Merck reports record results in a turbulent year
Mar 03, 2021: GPHL and Merck build strategic partnership on business innovation and development in GBA
Feb 25, 2021: MERCK REPORTS Info Financial Results 2020
Feb 25, 2021: Merck to manufacture next-generation biotherapeutics for Alteogen
Feb 24, 2021: Poxel announces completion of Arbitration with Merck Serono
Feb 24, 2021: Merck and Transylvanian Institute of Neuroscience cooperate on brain-inspired Artificial Intelligence
Feb 15, 2021: Merck enhances design for sustainability framework, Offers customers data-driven insights for greener solutions

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Affiliate
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont...1)
Merck KGaA, Annual Ratios (Cont...2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Merck KGaA, Performance Chart (2016 - 2020)
Merck KGaA, Ratio Charts
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Merck KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021